Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT02282930 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Progressive IgA Nephropathy
Proteinuria

Interventions

DRUG: ACTH (Acthar) Gel

Sponsor

Mayo Clinic

Collaborators

[object Object]